These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36241648)

  • 1. ARHGEF3 regulates the stability of ACLY to promote the proliferation of lung cancer.
    Zhou F; Ai W; Zhang Y; Hu Q; Gan M; Wang JB; Han T
    Cell Death Dis; 2022 Oct; 13(10):870. PubMed ID: 36241648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias.
    D'Amato L; Dell'Aversana C; Conte M; Ciotta A; Scisciola L; Carissimo A; Nebbioso A; Altucci L
    Epigenetics; 2015; 10(1):6-18. PubMed ID: 25494542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Leukaemia Associated Rho GEF (LARG/ARHGEF12).
    Ghanem NZ; Matter ML; Ramos JW
    Small GTPases; 2022 Jan; 13(1):196-204. PubMed ID: 34304710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Rho guanine nucleotide exchange factors in non-small cell lung cancer.
    Zeng RJ; Xie WJ; Zheng CW; Chen WX; Wang SM; Li Z; Cheng CB; Zou HY; Xu LY; Li EM
    Bioengineered; 2021 Dec; 12(2):11169-11187. PubMed ID: 34783629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Mg2+ cofactor in the guanine nucleotide exchange and GTP hydrolysis reactions of Rho family GTP-binding proteins.
    Zhang B; Zhang Y; Wang Z; Zheng Y
    J Biol Chem; 2000 Aug; 275(33):25299-307. PubMed ID: 10843989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho GEFs and GAPs: emerging integrators of extracellular matrix signaling.
    Kutys ML; Yamada KM
    Small GTPases; 2015; 6(1):16-9. PubMed ID: 25862162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ARHGEF3 as a GEF and mTORC2 Regulator.
    Khaliq SA; Umair Z; Yoon MS
    Front Cell Dev Biol; 2021; 9():806258. PubMed ID: 35174167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-specific Guanine nucleotide exchange factors (Rho-GEFs) inhibition affects macrophage phenotype and disrupts Golgi complex.
    Chen W; Zhao Y; Li XC; Kubiak JZ; Ghobrial RM; Kloc M
    Int J Biochem Cell Biol; 2017 Dec; 93():12-24. PubMed ID: 29061365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
    Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
    Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitination in Rho signaling.
    Ding F; Yin Z; Wang HR
    Curr Top Med Chem; 2011 Dec; 11(23):2879-87. PubMed ID: 21824110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Rho GEF and RhoA Activation by Pull-Down Assays.
    Sajib MS; Zahra FT; Akwii RG; Mikelis CM
    Methods Mol Biol; 2021; 2193():97-109. PubMed ID: 32808262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.
    Lin R; Tao R; Gao X; Li T; Zhou X; Guan KL; Xiong Y; Lei QY
    Mol Cell; 2013 Aug; 51(4):506-518. PubMed ID: 23932781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis.
    Liu TH; Zheng F; Cai MY; Guo L; Lin HX; Chen JW; Liao YJ; Kung HF; Zeng YX; Xie D
    Oncotarget; 2016 May; 7(18):25836-48. PubMed ID: 27028992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho Family GTPases and Rho GEFs in Glucose Homeostasis.
    Machin PA; Tsonou E; Hornigold DC; Welch HCE
    Cells; 2021 Apr; 10(4):. PubMed ID: 33923452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A High-Throughput Assay for Rho Guanine Nucleotide Exchange Factors Based on the Transcreener GDP Assay.
    Reichman M; Schabdach A; Kumar M; Zielinski T; Donover PS; Laury-Kleintop LD; Lowery RG
    J Biomol Screen; 2015 Dec; 20(10):1294-9. PubMed ID: 26195453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and functions of the RhoA regulatory guanine nucleotide exchange factor GEF-H1.
    Joo E; Olson MF
    Small GTPases; 2021; 12(5-6):358-371. PubMed ID: 33126816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical assays to characterize Rho GTPases.
    Jaiswal M; Dubey BN; Koessmeier KT; Gremer L; Ahmadian MR
    Methods Mol Biol; 2012; 827():37-58. PubMed ID: 22144266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression.
    Zhang C; Liu J; Huang G; Zhao Y; Yue X; Wu H; Li J; Zhu J; Shen Z; Haffty BG; Hu W; Feng Z
    Genes Dev; 2016 Sep; 30(17):1956-70. PubMed ID: 27664236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disrupting RhoA activity by blocking Arhgef3 expression mitigates microglia-induced neuroinflammation post spinal cord contusion.
    Liao L; Qian ZY; Li XY; Yang DS; Lei BJ; Li HJ; Hong X
    J Neuroimmunol; 2021 Oct; 359():577688. PubMed ID: 34390950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers.
    Schuld NJ; Hauser AD; Gastonguay AJ; Wilson JM; Lorimer EL; Williams CL
    Cell Cycle; 2014; 13(6):941-52. PubMed ID: 24552806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.